Huff and puff; repeatability of serial home PEF & FEV1 recording in a pharmaceutical trial

A. Harrison, E. Watson (Wallingford, Maids Moreton, United Kingdom)

Source: Annual Congress 2010 - Quality measurement and improvement in lung function
Session: Quality measurement and improvement in lung function
Session type: E-Communication Session
Number: 3967
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Harrison, E. Watson (Wallingford, Maids Moreton, United Kingdom). Huff and puff; repeatability of serial home PEF & FEV1 recording in a pharmaceutical trial. Eur Respir J 2010; 36: Suppl. 54, 3967

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Comparative in vitro performance of a new re-usable breath-actuated nebulizer (BAN) with other high performance systems intended for domiciliary use – 1: Table-top compressors
Source: Annual Congress 2012 - Translational respiratory medicine in asthma and COPD
Year: 2012


Peak expiratory flow monitoring – Optimal criterion for diagnosis of professional asthma?
Source: Annual Congress 2011 - The work environment in the clinic
Year: 2011

Comparative in vitro performance of a new re-usable breath-actuated nebulizer (BAN) with other high performance systems intended for domiciliary use – 2: Portable battery-compressor
Source: Annual Congress 2012 - The best of pharmacology treatments of airway diseases: new devices and drugs
Year: 2012


Clinical correlation & evaluation of spirometry in children with asthma
Source: Annual Congress 2011 - Biological correlates and comorbidities of childhood asthma/allergy
Year: 2011


Quality of forced spirometry in primary care practice – Are start of test, end of test and repeatability goals met?
Source: Annual Congress 2012 - Going with the flow: assessment and evaluation of airway function and its role in patient management
Year: 2012


Spirometer – Pass ATS/ERS test, but fail in real life
Source: Annual Congress 2012 - Life's a gas: aspects of respiratory gas exchange
Year: 2012



Accuracy of three activity monitors in patients with COPD – Validation by video
Source: Annual Congress 2011 - Physical activity monitors: from toy to valid tool?
Year: 2011

Spirometry quality control in a research centre – Does the quality depend on the pattern of spirometry?
Source: Annual Congress 2010 - Quality measurement and improvement in lung function
Year: 2010


Can we trust the SpO2 readings of the low-priced, miniature-pulse oximeter?
Source: Annual Congress 2009 - Gas exchange and exercise in respiratory diseases
Year: 2009


Six minute walk test in COPD – Comparison with spirometry
Source: Annual Congress 2010 - Innovations in the assessment of airway diseases
Year: 2010


Effects of positive expiratory pressure in patients with COPD – a systematic review
Source: Annual Congress 2009 - Treatment modalities in chest physiotherapy
Year: 2009


Early experience with home transcutaneous CO2 monitoring (TcCO2/SpO2) in the setting of a domiciliary assisted ventilation service
Source: Annual Congress 2010 - From the acute to the chronic patient: how do we use noninvasive ventilation?
Year: 2010


Transcutaneous measurement of pCO2 (ptcCO2): Time delay from change in alveolar pCO2 to first response in ptcCO2
Source: Annual Congress 2011 - Sleep and weight: heavy under pressure
Year: 2011



Peak expiratory flow (PEF) values obtained by the new EU scale (EN 13826). Wrights peak flow meter is comparable to those obtained by a pneumotach and turbine-based spirometer
Source: Eur Respir J 2007; 30: Suppl. 51, 124s
Year: 2007

The antitussive pentoxyverine (POV) does not affect the electrocardiogram (ECG), and in particular not the corrected QT (QTc) interval: Results from a phase I clinical trial
Source: International Congress 2014 – Clinical management of lung diseases: from bronchi to pleura
Year: 2014

Smoking assessment & treatment in hospital: Are we providing ‘right care‘ and/or missing cannabis-smoking?
Source: Annual Congress 2011 - Anti-smoking interventions: prevention and treatment
Year: 2011


The results of drug resistance survey of MDR-strains on second line drugs obtains in national reference laboratory – " M.Nasta " Institute – Bucharest
Source: Annual Congress 2011 - Epidemiology of multidrug-resistant and extensively drug-resistant tuberculosis
Year: 2011

Prospective analysis of lung function in COPD patients – home monitoring of FEV1 and PEF (PIKO®1)
Source: Eur Respir J 2006; 28: Suppl. 50, 108s
Year: 2006

Niv mortality in clinical practice – the 2008 UK national COPD audit
Source: Annual Congress 2009 - Healthcare and treatment of COPD
Year: 2009

Documentation & accuracy of smoking status – An educational need?
Source: Annual Congress 2011 - Smoking cessation science and smoking-related disorders
Year: 2011